 |
| Dear StockNews Member, I want to share with you more details on the two stellar growth picks that Jaimini Desai will be adding to his POWR Growth portfolio this Monday, August 30th. Here’s a preview of Jaimini’s 1st pick: “This company is one of the top-rated growth stocks in our database with a 99.5 Growth score. It designs and sells equipment and instruments used in delicate surgeries like neurosurgery and orthopedics. What’s particularly appealing is that it is forecasted to grow revenues at a rapid pace over the next 5 years. Combine that with gross margins of 64% leads to explosive upside potential.” Does that appeal to you? It should! And so too will Jaimini’s 2nd pick coming Monday that is one of the leading companies in the healthcare IT sector. This company combines the safety associated with healthcare stocks alongside the impressive growth that comes from being a technology company. This is an intoxicating blend of lower risk with serious reward. Both of these picks will only be shared with POWR Growth members. Gladly you can start a 30 day trial right now to get these picks when they are released on Monday. Start 30 Day Trial to POWR Growth Newsletter > > Just a reminder that the POWR Growth newsletter is backed by a unique trading strategy that has generated an average annual return of +46.42% a year since 1999. That is a full 551% better than the S&P 500. This is important to know because beyond these 2 fresh growth stocks, there are another 11 companies in the POWR Growth portfolio that have equally impressive upside potential. All you need to do is click the link below to get started today! Start 30 Day Trial to the POWR Growth Newsletter > > Wishing you a world of investment success!
Steve Reitmeister |
| This email was sent to edwardlorilla1986.paxforex@blogger.com You are receiving this email because you opted in at our website at StockNews.com. StockNews.com 146 W 29th Street, Suite 8E New York, NY 10001 Unsubscribe from this list |
| StockNews.com | Terms of Use | Performance | Privacy Policy |
No comments:
Post a Comment